9.89
9.89 (0%)
As of Feb 14, 2025
Mind Medicine [MNMD]
Source:
Company Overview
Mind Medicine is a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders. Our mission is to be the global leader in the development and delivery of treatments for brain health disorders that unlock new opportunities to improve patient outcomes.
| Country | United States |
| Headquarters | new york, new york |
| Phone Number | (212) 220-6633 |
| Industry | manufacturing |
| CEO | Robert Barrow |
| Website | www.mindmed.co |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | |
| Operating Profit | $-103.9 |
| Net Income | $-108.7 |
| Net Cash | $174 |
Profit Ratios
| Gross Margin | $0 |
| Operating Margin | |
| Profit as % of Revenues | |
| Profit as % of Assets | -50.9% |
| Profit as % of Stockholder Equity | -45% |
Management Effectiveness
| Return on Equity | -45% |
| Return on Assets | -36% |
| Turnover Ratio | |
| EBITA | $-103.9 |
Balance Sheet and Cash Flow Measures
| Total Assets | $302.2 |
| Total Liabilities | $60.7 |
| Operating Cash Flow | $-79.1 |
| Investing Cash Flow | |
| Financing Cash Flow | $253.2 |
